Deloitte veteran Mike Fucci strengthens risk and talent strategy at Acadia Healthcare
Acadia Healthcare has bolstered its board with a seasoned governance and operations leader, naming Mike Fucci to its board of directors, the company confirmed. Fucci, who joined as an independent director in October 2020, expands Acadia’s board to nine members as the behavioral health services provider pursues growth and operational stability.
Headquartered in Franklin, Tennessee, Acadia operates 582 facilities across 40 states, the United Kingdom and Puerto Rico, spanning inpatient psychiatric hospitals, specialty treatment sites, residential centers and outpatient clinics. The appointment of Fucci — a former executive of Deloitte U.S. — is intended to strengthen the board’s expertise in risk oversight, talent strategy and organizational transformation as Acadia scales.
Fucci retired in September 2020 after a long tenure at Deloitte. He served as Executive Chairman of Deloitte U.S. from 2015 to 2019 and held the title of Chairman Emeritus until his retirement. Earlier, he was Chief Operating Officer of Deloitte Consulting from 2009 to 2015 and served in multiple senior management roles since 2003. His board experience at Deloitte includes membership on the Deloitte U.S. Board of Directors beginning in 2013, leadership of the risk and regulatory committee, and participation in the committee that evaluates executive performance and compensation. In 2015 he joined the Deloitte Global Board of Directors, contributing to global governance and compensation committees.
Beyond corporate roles, Fucci co-founded and co-chaired the Board Leadership Forum, a coalition of Fortune 500 board chairs and lead directors focused on research and perspective-sharing around boardroom challenges. He also chaired the Deloitte Foundation, overseeing philanthropic initiatives supporting education in the United States.
“[Fucci] brings a unique perspective on human resource transformation, corporate talent strategies and risk mitigation that will complement the work and expertise of our other directors,” said Reeve Waud, chairman of Acadia’s board, in the company statement. Waud added that the board looks forward to Fucci’s contributions as Acadia seeks to deliver long-term value to shareholders.
Fucci’s blend of governance experience, operational leadership and focus on talent development positions him as a strategic addition to Acadia’s board as the company navigates regulatory, clinical and expansion priorities.
